Yuetai Co., Ltd.: cancellation of overdue guarantee of the company

Survival Rules for Turbulent Times: A Compilation of the 20 Most Unmissable Core Insights from the 2026 Tsinghua PBCSF Forum

A dialogue between Zhu Min, former Deputy Governor of the People's Bank of China and former Vice Managing Director of the International Monetary Fund; Michael Spence, 2001 Nobel Prize winner in Economics and Philip H. Knight Professor Emeritus of Management at Stanford Graduate School of Business; and Masaaki Shirakawa, former Governor of the Bank of Japan, at the 2026 Tsinghua PBCSF Global Finance Forum.

China-Built Vehicles Overtake German-Made Cars as South Korea’s Top Import Source

China has overtaken Germany as South Korea’s largest source of imported vehicles by manufacturing origin for the first time, as Shanghai-built Tesla models and expanding sales by BYD reshape one of Asia’s most competitive car markets.

Unpacking China | Key Chinese Firms to Watch This Week （26/07/2026-01/08/2026）

Amid fast-paced changes that fill the business community with excitement, angst and trepidation, EqualOcean will publish a series of roundup articles to document the major events related to Chinese companies going global every week.

Alphamab Licenses Cancer Drug to Pathos AI in Deal Worth More Than US$2.2 Billion

Alphamab Oncology (康宁杰瑞生物制药) has licensed the overseas rights to its experimental cancer drug JSKN016 to US-based Pathos AI in a deal potentially worth more than US$2.2 billion, marking another major overseas licensing agreement for China’s rapidly expanding innovative-drug sector.

Ningbo Ocean Shipping Launches First Europe-Bound Ro-Ro Service

On August 5, 2026, Ningbo Ocean Shipping Co., Ltd. (宁波远洋运输股份有限公司) launched its first roll-on/roll-off shipping service to Europe from Ningbo Zhoushan Port, marking the company’s entry into vehicle transportation and the first extension of its route network to the European continent.